Water

Water

SCHEMBL1801786

CCCCCCC(C)C(C)(C)N.O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 1/20 0.46
THRB known ✓ P10828 1/20 0.36
GRIK1 known ✓ P39086 1/20 0.36
GRIK2 known ✓ Q13002 1/20 0.36
SPHK1 Q9NYA1 2/20 0.43
LMNA P02545 2/20 0.38
TP53 P04637 2/20 0.38
DNM1 Q05193 2/20 0.37
CYP2D6 P10635 2/20 0.36
ADH1B P00325 1/20 0.36
ADH1C P00326 1/20 0.36
ADH1A P07327 1/20 0.36
ADH4 P08319 1/20 0.36
ADH7 P40394 1/20 0.36
PLA2G1B P04054 1/20 0.36
PLA2G2A P14555 1/20 0.36
GMNN O75496 1/20 0.36
POLB P06746 1/20 0.36
THPO P40225 1/20 0.36
MTOR P42345 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL2376537 1.00 OPRM1 (0.46) OPRM1SPHK1LMNATP53DNM1
Water SCHEMBL28466171 1.00 OPRM1 (0.46) OPRM1SPHK1LMNATP53DNM1
Water SCHEMBL992804 1.00 OPRM1 (0.46) OPRM1SPHK1LMNATP53DNM1
Water SCHEMBL8529604 1.00 OPRM1 (0.46) OPRM1SPHK1LMNATP53DNM1
Water SCHEMBL8062330 1.00 OPRM1 (0.46) OPRM1SPHK1LMNATP53DNM1
Ammonia Solution, Strong SCHEMBL28023979 0.98 OPRM1 (0.44) OPRM1SPHK1LMNATP53DNM1
SCHEMBL8383457 0.98 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1
SCHEMBL37786 0.98 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1
SCHEMBL8386214 0.98 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1
SCHEMBL125359 0.98 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115124049-A Method for synthesizing FER zeolite nanosheet with controllable thickness by using small-molecule template agent 浙江大学 2022-09-30 CN claimed
EP-2321221-B1 LOW COST ROUTES TO HIGH PURITY SILICON AND DERIVATIVES THEREOF MAYATERIALS INC (US) 2017-03-15 EP claimed
US-20130217872-A1 METHOD FOR PRODUCING COMPOSITE GEL BY CROSS-LINKING HYALURONIC ACID AND HYDROXYPROPYL METHYLCELLULOSE BEIJING AIMEIKE BIO-TECH CO., LTD. (CN) 2013-08-22 US claimed
US-8475758-B2 Low cost routes to high purity silicon and derivatives thereof MAYATERIALS, INC. (US) 2013-07-02 US claimed
US-8024943-B2 Method of dividing glass into separate pieces with the aid of a cutting liquid and improved cutting liquid for said method SCHOTT AG (DE) 2011-09-27 US claimed
US-20110206592-A1 LOW COST ROUTES TO HIGH PURITY SILICON AND DERIVATIVES THEREOF LAINE, RICHARD M 2011-08-25 US claimed
EP-2321221-A2 LOW COST ROUTES TO HIGH PURITY SILICON AND DERIVATIVES THEREOF Mayaterials, Inc. (US) 2011-05-18 EP claimed
WO-2010017364-A2 LOW COST ROUTES TO HIGH PURITY SILICON AND DERIVATIVES THEREOF MAYATERIALS, INC. (US) 2010-02-11 WO claimed
EP-1726635-B1 Process for severing glass and use of the cutting fluid suitable therefor SCHOTT AG (DE) 2009-09-02 EP claimed
US-20060266195-A1 Method of dividing glass into separate pieces with the aid of a cutting liquid and improved cutting liquid for said method SCHOTT AG (DE) 2006-11-30 US claimed
US-4169853-A HYDROGENATION, CATALYST SELECTIVITY TEXACO DEVELOPMENT CORPORATION (US) 1979-10-02 US claimed
CN-115124049-B Method for synthesizing FER zeolite nano-sheet with controllable thickness by using small molecular template agent 浙江大学 2023-07-21 CN disclosed
CN-115124049-A Method for synthesizing FER zeolite nanosheet with controllable thickness by using small-molecule template agent 浙江大学 2022-09-30 CN disclosed
EP-2321221-B1 LOW COST ROUTES TO HIGH PURITY SILICON AND DERIVATIVES THEREOF MAYATERIALS INC (US) 2017-03-15 EP disclosed
US-20160310522-A1 METHOD FOR PRODUCING COMPOSITE GEL BY CROSS-LINKING HYALURONIC ACID AND HYDROXYLPROPYL METHYLCELLULOSE AiMeike Technology Deveolpment., LTD 2016-10-27 US disclosed
EP-1568744-A1 COMPOSITION FOR POROUS FILM FORMATION, POROUS FILM, PROCESS FOR PRODUCING THE SAME, INTERLAYER INSULATION FILM AND SEMICONDUCTOR DEVICE MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2005-08-31 EP disclosed
US-20050090688-A1 Metallized mesoporous silicate and method of oxidation with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-04-28 US disclosed
US-20040219372-A1 Composition for forming porous film, porous film and method for forming the same, interlevel insulator film, and semiconductor device MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. 2004-11-04 US disclosed
EP-1473275-A1 METALLIZED MESOPOROUS SILICATE AND METHOD OF OXIDATION WITH THE SAME Sumitomo Chemical Company, Limited (JP) 2004-11-03 EP disclosed
US-4169853-A HYDROGENATION, CATALYST SELECTIVITY TEXACO DEVELOPMENT CORPORATION (US) 1979-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160310522-A1 METHOD FOR PRODUCING COMPOSITE GEL BY CROSS-LINKING HYALURONIC ACID AND HYDROXYLPROPYL METHYLCELLULOSE CD44, HAAO, HPGDS OPRM1 2140/4885THRB 4691/4885GRIK1 3390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.